The Pfizer BioNTech COVID-19 vaccine was authorised by US regulators to be used on children as young as 12. This widens the country’s vaccination program immensely as the rollout in the US has significantly slowed down. The jab was previously available under emergency use authorisation (EUA) to under-16s. The FDA amended this decision to include the younger age groups and have started the process for full approval last week. Acting FDA commissioner Janet Woodcock stated that ‘today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy.
She added that ‘parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorisations.’ Several countries have administered Pfizer to teens as young as 16, with Canada being the first to expand the age group to 12 and up.
Photo Source: Kaiser Health News